Docosahexaenoic acid and autism: praying for hope, or preying on hope

This link  takes you to an article about applications from behavioral analysis, which are currently used in the psychotherapeutic treatment of autism. But what if the key to autism is as relatively simple as improved nutrition either for the mother, for the infant, or for both? If, for example, levels of docosahexaenoic acid (DHA) are represented in important cellular aspects supporting hippocampus-related cognitive function?

Should the behavior analysts’ approach be compared to a biologically-based approach with a dietary supplement? DHA is important to neurite growth, synaptogenesis, synapsin, glutamatergic synaptic function and glutamate receptor expression. What may be a direct effect of DHA on glutamate receptor expression could link nutrition directly to autism during development in the womb, or in the postnatal period, especially during the first two years.  It might also link nutrition to genetically prediposed olfactory deficits, if any can be detailed in autistics — as well as to nutrient dependent /enzymatically-influenced deficits in the development of mirror neurons.

In this regard, my discussion attempts with participants in the human ethology yahoo group have led to complaints of psychology bashing (as indicated in my title here by “preying on hope”). I would be grateful to learn of where such things can be discussed — without such complaints.  Indeed, the article I have linked to in this post might be considered psychology bashing, if only because it focuses on claims of benefits compared to scientific evidence that supports the claims.


About James V. Kohl 1308 Articles
James Vaughn Kohl was the first to accurately conceptualize human pheromones, and began presenting his findings to the scientific community in 1992. He continues to present to, and publish for, diverse scientific and lay audiences, while constantly monitoring the scientific presses for new information that is relevant to the development of his initial and ongoing conceptualization of human pheromones. Recently, Kohl integrated scientific evidence that pinpoints the evolved neurophysiological mechanism that links olfactory/pheromonal input to genes in hormone-secreting cells of tissue in a specific area of the brain that is primarily involved in the sensory integration of olfactory and visual input, and in the development of human sexual preferences. His award-winning 2007 article/book chapter on multisensory integration: The Mind’s Eyes: Human pheromones, neuroscience, and male sexual preferences followed an award winning 2001 publication: Human pheromones: integrating neuroendocrinology and ethology, which was coauthored by disinguished researchers from Vienna. Rarely do researchers win awards in multiple disciplines, but Kohl’s 2001 award was for neuroscience, and his 2007 “Reiss Theory” award was for social science. Kohl has worked as a medical laboratory scientist since 1974, and he has devoted more than twenty-five years to researching the relationship between the sense of smell and the development of human sexual preferences. Unlike many researchers who work with non-human subjects, medical laboratory scientists use the latest technology from many scientific disciplines to perform a variety of specialized diagnostic medical testing on people. James V. Kohl is certified with: * American Society for Clinical Pathology * American Medical Technologists James V. Kohl is a member of: * Society for Neuroscience * Society for Behavioral Neuroendocrinology * Association for Chemoreception Sciences * Society for the Scientific Study of Sexuality * International Society for Human Ethology * American Society for Clinical Laboratory Science * Mensa, the international high IQ society